|
|
BOCA RATON, FL January 8, 2007 MDVIP, the breakthrough patient healthcare program committed to setting the gold standard of primary care in the U.S., announced today that The Procter & Gamble Company (NYSE:PG) has purchased a minority stake in the company. Terms of the deal were not disclosed.
This is a major step forward in MDVIPs rapid evolution as the model for delivery of exceptional healthcare results for American patients. With the knowledge, resources and leverage that P&G brings to the table, MDVIP will be able to continuously offer increasingly dynamic healthcare solutions for both patients and physicians, said Edward E. Goldman, M.D. President and Chief Executive Officer, MDVIP.
MDVIP works with the nations finest physicians to give them the tools they need to practice preventive and personalized healthcare for patients who consider their health a priority. The MDVIP model is based on three pillars:
exceptional doctors, exceptional care, and exceptional results.
P&G has been looking at MDVIP for a year now and during that time, it has become very clear to us that they have created a unique and very compelling health care services model, said Nathan Estruth, General Manager at P&G who leads the relationship with MDVIP. This partnership creates value for both companies by leveraging our individual strengths. It is consistent with P&Gs mission to improve the lives of consumers in the important areas of health and wellness.
|
|
|
|